Company Genscript Biotech Corporation

Equities

1548

KYG3825B1059

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Genscript Biotech Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 04:08:16 2024-04-24 am EDT			5-day change	1st Jan Change
10.84 ^HKD	-1.28%		-6.87%	-45.42%

Apr. 23	Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	CI
Apr. 23	Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission	MT

Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Number of employees: 6,937

HKD in Million	2022	Weight	2023	Weight	Delta
Life-science Services and Products 48.2 %	2,739	55.9 %	3,167	48.2 %	+15.62%
Cell Therapy 33.9 %	914	18.6 %	2,231	33.9 %	+144.18%
Biologics Development Services 12.7 %	941	19.2 %	835	12.7 %	-11.23%
Industrial Synthetic Biology Products 5.1 %	299	6.1 %	336	5.1 %	+12.18%
Operation Unit 0.1 %	7	0.1 %	4	0.1 %	-42.83%

HKD in Million	2022	Weight	2023	Weight	Delta
United States 60.3 %	2,600	53.1 %	3,961	60.3 %	+52.32%
China 19.4 %	1,306	26.7 %	1,273	19.4 %	-2.54%
Europe 11.9 %	417	8.5 %	779	11.9 %	+86.73%
Asia Pacific (excluding China) 6.3 %	462	9.4 %	417	6.3 %	-9.81%
Others 2.2 %	114	2.3 %	143	2.2 %	+25.58%

Managers	Title	Age	Since
Weihui Shao CEO	Chief Executive Officer	-	22-12-31
Ye Wang FOU	Founder	55	01-12-31
Shiniu Wei DFI	Director of Finance/CFO	-	-
Jian Ge Meng CHM	Chairman	55	10-03-31
Li Zhu BRD	Director/Board Member	74	09-12-31
Berkan Unal PRN	Corporate Officer/Principal	-	-
Jing Jing Hua AUD	Comptroller/Controller/Auditor	-	-
Wai Ling Wong SEC	Corporate Secretary	45	15-08-23

Members of the board	Title	Age	Since
Hong Xin Guo BRD	Director/Board Member	61	15-08-23
Li Zhu BRD	Director/Board Member	74	09-12-31
Xue Hai Wang BRD	Director/Board Member	50	20-11-21
Jia Fen Wang BRD	Director/Board Member	73	18-11-25
Zu Mian Dai BRD	Director/Board Member	47	15-08-23
Fang Liang Zhang CEO	Chief Executive Officer	59	01-12-31
Lu Quan Wang FOU	Founder	54	01-12-31
Ye Wang FOU	Founder	55	01-12-31
Jian Ge Meng CHM	Chairman	55	10-03-31
Jiu An Pan BRD	Director/Board Member	56	18-11-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,124,027,670	1,147,683,091 ( 54.03 %)	0	54.03 %

Name	Equities	%	Valuation
GenScript Corp. 37.67 %	799,999,123	37.67 %	1 482 M $
Fang Liang Zhang 8.040 %	170,753,326	8.040 %	316 M $
Wang Ye Family 3.172 %	67,373,095	3.172 %	125 M $
GF Fund Management Co., Ltd. 1.012 %	21,494,321	1.012 %	40 M $
Foresight Fund Management Co., Ltd. 0.5471 %	11,620,000	0.5471 %	22 M $
Bosera Asset Management Co., Ltd. 0.5222 %	11,090,000	0.5222 %	21 M $
HuaAn Fund Management Co., Ltd. 0.5033 %	10,690,000	0.5033 %	20 M $
Zhong Ou Asset Management Co., Ltd 0.4955 %	10,524,068	0.4955 %	19 M $
Penghua Fund Management Co., Ltd. 0.4840 %	10,280,000	0.4840 %	19 M $
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.4475 %	9,504,000	0.4475 %	18 M $

Name	Equities	%	Valuation
LEGEND BIOTECH CORPORATION 60.32%	174,497,556	60.32%	4,893,783,958 $

Genscript Biotech Corp.

No. 28, Yongxi Road Jiangning Science Park

210000, Nanjing

+86 25 5889 7288

http://www.genscript.com

address Genscript Biotech Corporation(1548)

Name	Category and Sector
LEGEND BIOTECH CORPORATION	Pharmaceuticals: Major
Probio Technology Ltd. (George Town) Probio Technology Ltd. (George Town) BiotechnologyHealth Technology Probio Technology Ltd. (Cayman Islands) is a company based in George Town, the Cayman Islands.	Biotechnology

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.401 USD

Average target price

3.688 USD

Spread / Average Target

+163.23%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENSCRIPT BIOTECH CORPORATION	-45.42%	2.98B
IQVIA HOLDINGS INC.	+4.70%	43.43B
LONZA GROUP AG	+47.64%	41.69B
MODERNA, INC.	+10.68%	41.31B
CELLTRION, INC.	-10.82%	27.14B
ICON PUBLIC LIMITED COMPANY	+10.04%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-24.40%	18.47B
MEDPACE HOLDINGS, INC.	+34.92%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+2.57%	12.33B
UNITED THERAPEUTICS CORPORATION	+8.46%	11.03B

Other Biotechnology & Medical Research